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ARTICLE
Proﬁling human breast epithelial cells using single
cell RNA sequencing identiﬁes cell diversity
Quy H. Nguyen1, Nicholas Pervolarakis2, Kerrigan Blake2, Dennis Ma1, Ryan Tevia Davis3, Nathan James1,
Anh T. Phung3, Elizabeth Willey4, Raj Kumar4, Eric Jabart5, Ian Driver4, Jason Rock4, Andrei Goga 6,
Seema A. Khan7, Devon A. Lawson3, Zena Werb 4 & Kai Kessenbrock1
Breast cancer arises from breast epithelial cells that acquire genetic alterations leading to
subsequent loss of tissue homeostasis. Several distinct epithelial subpopulations have been
proposed, but complete understanding of the spectrum of heterogeneity and differentiation
hierarchy in the human breast remains elusive. Here, we use single-cell mRNA sequencing
(scRNAseq) to proﬁle the transcriptomes of 25,790 primary human breast epithelial cells
isolated from reduction mammoplasties of seven individuals. Unbiased clustering analysis
reveals the existence of three distinct epithelial cell populations, one basal and two luminal
cell types, which we identify as secretory L1- and hormone-responsive L2-type cells. Pseu-
dotemporal reconstruction of differentiation trajectories produces one continuous lineage
hierarchy that closely connects the basal lineage to the two differentiated luminal branches.
Our comprehensive cell atlas provides insights into the cellular blueprint of the human breast
epithelium and will form the foundation to understand how the system goes awry during
breast cancer.
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Breast cancer is a highly heterogeneous disease that is sub-typed based on tissue morphology and molecular sig-natures1. At least six different intrinsic subtypes of breast
cancers have been established, namely luminal A, luminal B,
HER2-enriched, basal-like, normal breast, claudin-low2, and
more recently up to ten subtypes have been described3. Each
subtype is speculated to arise from a different cell of origin4;
however, gaps in our understanding of the full spectrum of cel-
lular heterogeneity and the distinct cell types that comprise the
human breast epithelium hinder our ability to investigate their
roles in cancer initiation and progression.
Breast cancer arises from the breast epithelium, which forms a
ductal network embedded into an adipose tissue that connects the
nipple through collecting ducts to an intricate system of 12–20
lobes, which are the milk producing structures during pregnancy
and lactation. Throughout the duct and lobular system, the breast
epithelium is composed of two known cell types, an inner layer of
secretory luminal cells and an outer layer of basal/myoepithelial
cells. A series of recent reports have indicated that further het-
erogeneity exists within these two cell layers in mice4. Two
landmark papers published in 2006 identiﬁed a functionally
distinct subpopulation of basal epithelial cells that harbors stem
cell capacity and is capable of reconstituting a fully developed
mammary epithelial network when transplanted into the cleared
mammary fat pads of mice5,6. Moreover, a subpopulation of
luminal progenitor cells identiﬁed by high expression of KIT as
well as a subpopulation of mature luminal cells have been iden-
tiﬁed using ﬂow cytometry (FACS) isolation strategies7,8. Inter-
estingly, based on comparative bulk expression analyses, these
luminal progenitors may have increased propensity to give rise to
triple negative breast cancers in patients with mutations in the
BRCA1 gene9. It remains to be determined if other distinct cell
types exist within the breast epithelium and how these relate to
the known subtypes of breast cancer.
Advances in next generation sequencing and microﬂuidic
based handling of cells and reagents now enable us to explore
cellular heterogeneity on a single cell level and reconstruct lineage
hierarchies using single-cell mRNA sequencing (scRNAseq)10,11.
This approach allows an unbiased analysis of the spectrum of
heterogeneity within a population of cells, since it utilizes tran-
scriptome reconstruction from individual cells. scRNAseq has
been successfully applied to understand the complex sub-
populations in normal tissues such as lung11 or brain10 as well as
in various cancers including melanoma12, glioblastoma13, and
within circulating tumor cells from patients with pancreatic
cancer14.
The goal of the present study is to generate a molecular census
of cell types and states within the human breast epithelium using
unbiased scRNAseq. Focusing on the breast epithelium, our work
provides a critical ﬁrst impetus toward generating large-scale
single cell atlases of the tissues comprising the human body as
part of the international human cell atlas initiative15. This
molecular census can shed light on lineage relationships and
differentiation trajectories in the human system and how it relates
to breast cancer. Our single-cell transcriptome analysis provides
unprecedented insights into the spectrum of cellular hetero-
geneity within the human breast epithelium under normal
homeostasis and will serve as a valuable resource to understand
how the system changes during early tumorigenesis and tumor
progression.
Results
scRNAseq reveals three cell types in the breast epithelium. We
collected a cohort of reduction mammoplasties from age- and
ethnicity-matched, post-pubertal and pre-menopausal females
(Supplementary Data 1), and performed scRNAseq on puriﬁed
breast epithelial cells, which were isolated from surrounding
stromal cells using ﬂow cytometry based on differential expres-
sion of CD49f and EpCAM16. Basal and luminal cells were
separately loaded onto the Fluidigm C1 microﬂuidics-enabled
scRNAseq platform (Fig. 1a). Capture efﬁciency was monitored
by microscopic imaging to exclude doublets and debris from
further analysis (Supplementary Fig. 1a, b). We used 13 C1 chips
in total to capture and sequence transcriptomes of 868 cells from
three human individuals. The resulting single cell cDNA libraries
were sequenced in parallel at an average read depth of 1.6 M reads
per cell. After removing cells with less than 900 genes detected
and additional quality control ﬁltering (see Methods section), we
proceeded to analyze 703 single cell at ~4500 genes detected on
average per cell, where the gene detection range was comparable
between basal and luminal cells (Supplementary Fig. 1c).
To identify the main cell types within the breast epithelium
that are generalizable across individuals, we performed a
combined analysis of all cells from the three individuals using
the recently described Seurat pipeline17. This analysis identiﬁed
three very distinct clusters of cells (Fig. 1b), indicating that the
breast epithelium is composed of three main cell types. We then
explored the genes that are signiﬁcantly up-regulated within each
cluster (Fig. 1c), which revealed that these main clusters
correspond to one major basal (KRT14+; AUC= 0.83) cell type
and two luminal cell types that both express the typical markers
KRT8 and KRT18. Importantly, cells representing all three cell
types were detected in each of the three individuals (Supplemen-
tary Fig. 1d). We found several distinct markers for these luminal
cell types such as SLPI (AUC= 0.89) for L1, and ANKRD30A
(AUC= 0.81) for L2 (Supplementary Fig. 1e). Comparing these
signatures to previously published microarray expression analyses
of FACS-isolated human breast epithelial cells9,18, we found that
L1 corresponds closely to the CD49f+/EpCAM+ population
designated as “luminal progenitors,” L2 resembles the CD49f
−/EpCAM+ population called “mature luminal,” and the basal
cluster matched with CD49fhi/EpCAM− “Basal/MaSC.” Since
basal cells contain a subset of mammary stem cells (MaSCs)5,6,19,
we examined the basal cell cluster in more detail. Particularly
intriguing was the observation of a subset with increased
expression of mesenchymal and stem cell markers ZEB120 and
TCF4 (Fig. 1d). Interestingly, previous work established a direct
link between mesenchymal gene expression signatures and MaSC
capacity21, suggesting these ZEB1/TCF4-expressing cells may
represent a subset of basal cells with increased MaSC potential.
Droplet-mediated scRNAseq reveals subpopulation diversity.
To determine whether additional cellular diversity exists, we next
utilized a more scalable droplet-mediated scRNAseq platform
(10× Genomics Chromium)22. Here, we focused on reduction
mammoplasty samples from nulliparous women (Supplementary
Data 1) to reduce variability associated with pregnancy-related
changes of the breast. We isolated both luminal and basal cells
together (EpCAM+/CD49fhi/lo) by ﬂow cytometry and subjected
them as one sample to droplet-based scRNAseq targeting on
average 5000 cells per sample (Fig. 2a). We sequenced a total of
24,646 cells from four individuals (Ind4-7) at an average ~60,000
reads per cell.
After quality control ﬁltering to remove cells with low gene
detection (<500 genes) and high mitochondrial gene coverage
(>10%), detailed clustering analysis of the ﬁrst individual (Ind4)
using Seurat conﬁrmed the existence of three main epithelial cell
types, namely Basal (KRT14+), Luminal1 (L1; KRT18+/SLPI+)
and Luminal2 (L2; KRT18+/ANKRD30A+) (Fig. 2b). All marker
genes are listed in Supplementary Data 2. These analyses also
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revealed three additional small clusters; cluster 8 was deﬁned by
stromal marker VIM (P < 9.6 × 10−25); cluster 9 showed speciﬁc
expression of endothelial marker gene ESAM (P < 4.1 × 10−30);
and cluster 10 included a small number of dispersed cells most
likely representing outliers. We concluded that these clusters
(8–10) were of non-epithelial nature and denoted them as
unclassiﬁed (X) in further analyses.
Interestingly, multiple subclusters emerged within each of the
main epithelial cell types as indicated by their distinct marker
gene signatures (Fig. 2c). We hypothesized that the main islands
of cells (Basal, L1, L2) represent distinct “cell types”, whereas
subclusters within each island depict “cell states” that are more
transient over time23. Within basal cells we detected three distinct
cell states, which showed speciﬁc expression of inﬂammatory
mediators (IL24; P < 1.4 × 10−180; Cluster 3), markers for
myoepithelial cell function (ACTA2; P < 7.4 × 10−292; Cluster 4)
and speciﬁc epithelial keratin expression (KRT17; P < 1.6 × 10−38;
Cluster 5), respectively. ZEB1 and TCF4, which marked a subset
of basal cells in our microﬂuidics-enabled scRNAseq analysis
(Fig. 1d), were lowly detected and therefore not interpretable in
droplet-enabled scRNAseq, which is likely due to lower coverage
compared to the microﬂuidics-enabled platform24.
Within luminal cell type L1 we observed three distinct cell
states that were marked by genes associated with milk production
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Fig. 1 Identiﬁcation of three major epithelial cell types and their markers using scRNAseq. a Overview of scRNAseq approach using primary human breast
tissue samples that were processed into single cell suspension, followed by FACS isolation of basal (CD49f-hi, EPCAM+) and luminal (CD49f+, EPCAM-
hi), and scRNAseq analysis using the microﬂuidics-enabled scRNAseq. b Combined tSNE projection of cells from all three microﬂuidics-enabled scRNAseq
datasets. The major basal cluster is highlighted in red; Luminal1 (L1) in green; Luminal2 (L2) in blue. c Heatmap displaying the scaled expression patterns of
top marker genes within each cell type with selected marker genes highlighted; yellow indicating high expression of a particular gene, and purple indicating
low expression. d Feature plots showing the scaled expression of TCF4 and ZEB1 marking a subpopulation of basal cells and gene plot showing co-
expression of TCF4 and ZEB1 in the same cells. See Supplementary Fig. 1 capture site imaging, gene detection, individual principal component analysis,
tSNE plot colored by individual-derived cells and feature plots of cell type-speciﬁc markers
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Fig. 2 High throughput droplet-mediated scRNAseq reveals additional epithelial cell states. a Overview for droplet-enabled scRNAseq approach as
described above; basal and luminal epithelial cells were sorted together and subjected to combined scRNAseq analysis using the droplet-based scRNAseq.
b Data from individual four was analyzed using Seurat and the distinct clusters (0–10) are displayed in tSNE projection with selected marker gene for each
cluster, and main epithelial cell types (Basal, L1, L2) are outlined. Feature plots of characteristic markers for the three main cell types are shown on the right
showing expression levels as gradient of purple. c Heatmap showing the top ten marker genes for each cluster as determined by Seurat analysis with three
selected genes per cluster highlighted on the right. See Supplementary Fig. 2 for individual clustering and marker gene analyses for Individuals 5–7
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(LTF; P < 8.4 × 10−270; Cluster 1), high expression of secretory
molecules (SAA2; P < 2.2 × 10−90; Cluster 0) and distinct
epithelial keratin expression (KRT23; P < 2.5 × 10−157; Cluster
2). The second luminal cell type L2 harbored two distinct cell
states that were marked by expression of hormone responsive
genes (AGR2; P < 3.1 × 10−144; Cluster 6) and speciﬁc cell surface
markers (CD74; P < 2.9 × 10−121; Cluster 7). We next performed
detailed individual Seurat clustering analyses for three additional
individual datasets from nulliparous women, which conﬁrmed
many of the patterns described for Ind4 (Fig. 2). Like Ind4, the
other individuals possessed three main cell clusters clearly
corresponding to cell types Basal, L1, and L2, and eight to ten
subclusters (Supplementary Fig. 2a–c). The number of subclusters
per cell type varied across the individuals with Ind5 comprising
ﬁve Basal, three L1 and one L2 clusters, Ind6 containing seven
Basal, three L1 and one L2 clusters, and Ind7 comprising one
Basal, three L1 and ﬁve L2 clusters (Supplementary Fig. 2a–c),
which may be due to individual-to-individual variation or
anatomical location of the surgical specimens.
To determine cell states that are generalizable across
individuals, we developed a comparative approach using a cell
scoring method adapted from recently published work12. Using
the marker gene signatures for each of the 11 clusters (0–10)
detected in Ind4 (Fig. 2b, c), we performed pairwise gene scoring
analyses to ﬁnd matches for every distinct cluster identiﬁed in
Ind5–7 (Supplementary Fig. 2a–c). Comparing Ind4 to
Ind5–7 showed that the main cell types (Basal, L1, L2) readily
match up across all individuals (Fig. 3a–c). In addition, it revealed
that the there are two distinct cell states present within L1 (L1.1
and L1.2) that emerge in all four individuals. The L2 population,
which contained two clusters in Ind4, was found to be more
homogeneous, and therefore these clusters were combined to a
single L2 population. Comparing basal subclusters between
individuals suggested that there are at least two generalizable
cell states within basal cells (Fig. 3a–c). To further explore this, we
performed a separate Seurat analysis using combined basal cells
from all four individuals (Supplementary Fig. 3a). Several clusters
displayed consistently high expression of genes associated with
myoepithelial cell function (e.g., ACTA2, TGLN, KRT14). We
therefore generated a “myoepithelial cell signature” gene list
(Supplementary Data 2) based on published work25 to stratify
basal cells into either a “Basal” or “Myoepithelial” grouping
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Fig. 3 Combined droplet based RNAseq data to identify generalizable cell types and states. a–c Heatmaps showing gene scoring results using marker genes
for Ind4 clusters (0–10; on bottom of heatmap) in all clusters from Ind5 (a), Ind6 (b), and Ind7 (c). Individual-speciﬁc cluster IDs are shown in different
colors on the right and bottom, and cell type IDs for Basal (b), L1, L2, X are indicated on for every cluster. Data shown as Z scores from purple (low) to
yellow (high). Two distinct cell states L1.1 and L1.2 were found within L1 in all pairwise comparisons as highlighted by colored boxes on heatmap. d
Combined tSNE projection of all individual datasets (outlined) is shown including the cell state identity marked by different colors. e Heatmap showing the
expression pattern of the top ten markers per cell state with selected markers indicated (yellow= high expression; purple= low expression). See
Supplementary Fig. 4 for separate basal cell Seurat analysis, summary of cell state designations and Ingenuity Pathway Analysis
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(Supplementary Fig. 3b, c). These results allowed us to include all
individual-speciﬁc clusters into the ﬁnal cluster designations,
namely Basal (B), Myoepithelial (Myo), Luminal1.1 (L1.1),
Luminal1.2 (L1.2), Luminal2 (L2), and the small Unclassiﬁed
(X) as summarized in Supplementary Fig. 3c. These designations
were used to perform a combined Seurat analysis of all 24,465
cells from four individuals (Fig. 3d), which enabled us to
determine the common marker genes (e.g., B: APOD; Myo:
TAGLN; L1.1: LTF; L1.2: CLDN4; L2: AGR2) for each cell state
that are generalizable across all four individuals (Fig. 3e).
To learn more about the biology underlying these cell states,
we used Ingenuity Pathway Analysis (IPA) to identify distinct
signaling pathways (Supplementary Fig. 3d), and interrogated for
transcription factor consensus sites using the Enrichr tool26
(Supplementary Data 2). These analyses revealed that the Myo
state might be controlled by the transcription factors TP63 and
PPARγ, and is deﬁned by increased integrin and paxillin
signaling indicating that these cells provide physical integrity
within the breast epithelial architecture. The B state was found to
be linked to transcription factors STAT3 as well as SOX2,
NANOG, and KLF4, which are associated with stem cell capacity
and cellular plasticity27, suggesting that population B may harbor
MaSCs. Within the luminal compartment, L1.1 showed distinct
signatures of iNOS and IL6 signaling that may indicate a sentinel
function of tissue harm and inﬂammation associated with this
cell state. L1.2 displayed increased levels of PI3K/AKT and
glucocorticoid signaling, which may indicate a link to steroid
hormone signaling for this cell population. Within the second
luminal cell type L2 we found evidence for elevated mTOR
signaling as well as aldosterone signaling in epithelial cells, which
suggests that this cell type represents a hormone-responsive cell
population.
Spatial integration of cell types and states. We next used
indirect immunoﬂuorescence analysis to validate our scRNAseq
ﬁndings on the protein level and to spatially integrate newly
discovered cell types and states into the anatomy of the breast.
We ﬁrst focused on the cell states detected within the basal
compartment. Immunostaining for ZEB1, which we identiﬁed in
a subset of basal cells in microﬂuidics-enabled scRNAseq
(Fig. 1d), showed that this protein is indeed expressed in a small
fraction of basal epithelial cells (Fig. 4a). High ZEB1 and medium
KRT14 levels have been recently described in a population of
protein C receptor (ProCR) expressing murine MaSCs with
in vitro and in vivo stem cell activity19. Comparison of published
gene expression signatures of ProtCR+ MaSCs with the ZEB1+
population identiﬁed here showed striking similarity (Fig. 4b),
suggesting that the ZEB1+ basal cells may represent a population
of human MaSCs. In addition, staining for TCF4, revealed a
comparable staining pattern to ZEB1 within the basal (smooth
muscle actin-positive) compartment (Fig. 4c). These ﬁndings
show that the cell state characterized by ZEB1 and TCF4
expression exists within the basal compartment in intact breast
tissue.
KRT14 expression is a hallmark for basal cells, and our
differential gene expression analysis conﬁrmed that KRT14 is
predominantly expressed within basal cells. However, it exhibited
surprising variability across all basal cell population with
particularly high expression in the Myo cell state (Fig. 4d).
Immunoﬂuorescence analysis for KRT14 conﬁrmed this, and
revealed that KRT14 high cells localized to the basal cell layer
within ductal regions, while lobular basal cells generally displayed
lower and more variable staining for KRT14 (Fig. 4e). Myo cells
also expressed high levels of the deﬁnitive myoepithelial marker
ACTA2 (Supplementary Fig. 4a), as well as other genes associated
with smooth muscle differentiation and function in other tissues
such as MYLK, MYL9, and TAGLN/Transgelin28.
Surprisingly, basal and luminal markers were not always
exclusive and we noted a distinct fraction of cells that co-express
luminal- (e.g., KRT8) and basal- (e.g., KRT14) speciﬁc genes, as
shown by correlation analysis of our single cell expression data
(Supplementary Fig. 4b). To determine whether this population
exists in the intact tissue, we performed in situ co-localization
analysis by immunoﬂuorescence staining for KRT8 and KRT14.
While most areas within the human breast epithelium showed the
expected luminal KRT8+/KRT14− or basal KRT8−/KRT14+
pattern, we observed several rare loci within lobular regions of the
tissue that indeed showed distinct KRT8+/KRT14+ patterns
(Supplementary Fig. 4c). Although this cell state has been
previously observed in mouse fetal MaSCs29, our work revealed
that this state exists in the human tissue in adult homeostasis.
The scRNAseq analyses revealed that the luminal compartment
harbors two discrete epithelial cell types (L1, L2). To determine if
L1 and L2 correspond to ductal and lobular anatomical location
within the tissue, we used speciﬁc markers for L1 (SLPI) and L2
(ANKRD30A) to identify their spatial distribution within the
breast tissue using in situ immunoﬂuorescence. These analyses
showed that both L1 and L2 are located next to each other within
both ducts and lobules (Fig. 5a). We next sought to determine
their hormone signaling status. Annotation of the single cell
datasets shows that L2 is particularly enriched for ESR1, PGR, and
AR (Supplementary Fig. 5a), although generally these genes were
found to be lowly expressed. Consistent with this observation, we
also found on the protein-level that L2 marker ANKRD30A
commonly overlaps with ER (32.4% of cells), PR (38.0%), and AR
(46.8%), whereas SLPI-positive cells showed markedly lower
percentage of hormone receptor expression (Fig. 5b–d). PGR was
also expressed in a sub-fraction of basal cell states, although PR
was not detected in basal cells on the protein level (Fig. 5c).
Proliferation is associated with active progenitor cell capacity
within adult epithelial tissues30. Interestingly, we observed
proliferative cells in all three epithelial cell types (Basal, L1, L2)
as evident on the RNA level (Supplementary Fig. 5b) and using
Ki67 immunostaining (Fig. 5e–f). Moreover, expression of
CDKN1B (p27), which has been previously linked with a
quiescent, hormone-responsive progenitor cell population31,
was found highest in L2 (Supplementary Fig. 5b), while markers
for alveolar luminal progenitor cell function such as ELF532 and
KIT7,8 were speciﬁcally enriched in luminal subpopulation L1.1
(Supplementary Fig. 5c).
L2 was also characterized by higher levels of KRT8 than L1
(Fig. 5g). To quantify protein expression in individual cells, we
utilized a recently developed single-cell western blot application
(ProteinSimple, Milo), which performs electrophoretic separation
of the protein content of about 2000 cells per chip and
subsequently probed with ﬂuorescently labeled antibodies.
Applying single-cell western blotting to luminal and basal cells
isolated by FACS identiﬁed three cell states, namely KRT8-
negative, -low, and -high (Fig. 5h–i), which illustrates the
usefulness of single cell Western blotting as a quantitative
validation tool downstream of scRNAseq analyses.
Taken together, these analyses conﬁrmed remarkable con-
cordance between the patterns observed in scRNAseq and on the
protein-level in intact tissues. Our spatial analyses conﬁrmed that
the luminal compartment contains two distinct cell types (L1 and
L2) that intermingle within ducts and lobules. Both contain a
subset of proliferative cells, suggesting that they each contain L1-
and L2-committed progenitor cells to maintain these cell types.
Based on their expression signatures, L1 may be committed to
secretory function, while L2 likely functions as a hormone-
sensing unit of the breast epithelium.
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Reconstructing lineage hierarchies within the epithelium. To
understand how these observed cell types and states are related
to each other, we next reconstructed differentiation trajectories
by pseudotemporal ordering of single cells using Monocle,
which utilizes reverse graph embedding to generate a trajectory
plot that can account for both branched and linear differ-
entiation processes33. Applying Monocle to our droplet-based
scRNAseq dataset on a subsampled population (4000 cells; 1000
cells per individual) from all four individuals yielded one tightly
connected differentiation trajectory that separates into three
main branches corresponding to the main cell types Basal, L1
and L2 (Fig. 6a). This suggests that the system is maintained
through one continuous rather than several disconnected
lineages. Considering the substantial evidence supporting the
existence of MaSCs within the basal cell compartment5,6, we
manually set the start of pseudotime within the basal cell type
(Fig. 6b), thus resulting in a trajectory that differentiates into
three main branches that are each enriched for Myo, L1 and L2,
respectively. Of note, L1.2 is markedly enriched at the
branching point between L1 and L2, suggesting that it repre-
sents a luminal-restricted bi-potent progenitor. It also precedes
L1.1 on the L1 branch, suggesting that L1.2 is a progenitor to
L1.1. Interestingly, L1.1 displayed high ELF5 and KIT expres-
sion, which have been previously reported as progenitor cell
markers7,8. Our data instead suggests that L1.1 represents a
second mature, differentiated luminal cell type rather than a
luminal progenitor that is upstream of L2. These basic princi-
ples were also reﬂected in our pseudotemporal analysis of the
microﬂuidics-enabled scRNAseq dataset, which projects a
bifurcation into luminal and basal lineage emerging from one
common population of ZEB1+ progenitor cells (Supplemen-
tary Fig. 6a b). These results are in line with previous models of
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mammary differentiation mediated by bi-potent stem/pro-
genitor cells4.
Subpopulations correspond to breast cancer subtypes. To learn
more about the relationship of these newly deﬁned subpopula-
tions to existing subtypes of breast cancer, we used our gene
scoring approach to directly compare the gene signatures of each
population to gene signatures associated with each cancer subtype
from the Metabric dataset34. This showed that both Luminal A
and Luminal B subtypes of breast cancer are closely related to L2-
type luminal cells (Supplementary Fig. 6c, top), which is in line
with previous gene signature analyses of FACS-enriched basal,
luminal progenitor, and mature luminal cells9. In addition, a
recent report by Lehman et al. used global gene expression ana-
lyses to identify molecularly distinct subtypes within triple
negative breast cancer (TNBC)35. We found that Myo showed
highest similarity to the mesenchymal-like subtype of TNBC,
while the Basal1 class of TNBC yielded highest scores in the
luminal L1.1 state (Supplementary Fig. 6c, bottom). Taken
together, these analyses allow us to directly link several deﬁned
breast cancer subtypes to distinct cell populations of epithelial
cells suggesting that the subtypes of breast cancer may arise from
different tumor cells-of-origin.
Discussion
The current state of knowledge in breast epithelial biology is
largely based on population-level analyses of separated basal and
luminal cells following bulk analyses of these distinct epithelial
cell types7. While several distinct subpopulations of murine basal
and luminal cells have been reported anecdotally4, comprehensive
knowledge about expression signatures and cellular identities of
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these subpopulations remains sparse, particularly in the human
system. Our scRNAseq analysis of the human breast epithelium
from non-diseased, post-puberty, pre-menopause individuals for
the ﬁrst time allow for unbiased, de novo identiﬁcation of distinct
cell types and states in the adult human breast epithelium before
pregnancy-induced changes occur. Strikingly, our approach
revealed the existence of three main epithelial cell types (Basal, L1
and L2), in line with a recent scRNAseq analysis of the mouse
mammary gland36, although this work referred to these popula-
tions as “basal”, “luminal progenitor” and “mature luminal cells”.
Our spatial analyses showed that these three cell types inter-
mingle within ducts and lobules, and appear to form functionally
distinct lineages that contribute to different aspects of breast
biology (summarized in Fig. 7a). The fact that all three cell types
contained a fraction of proliferative cells suggests that each cell
type may be maintained by cycling, lineage-restricted progenitor
cell subpopulations during normal homeostasis.
Our unbiased clustering analysis and pseudotemporal recon-
struction of differentiation trajectories strongly suggest that these
cell types represent three main branches of speciﬁed, differ-
entiated cells, namely basal/myoepithelial, secretory L1, and
hormone-responsive L2 cells (Fig. 7b). The lineage hierarchy
likely starts with basal MaSCs5,6 that differentiate either into
speciﬁed myoepithelial cells, or into a common luminal pro-
genitor, which gives rise to the two distinct luminal cell types L1
and L2. Interestingly, the ELF5/KIT-expressing subpopulation
L1.1 represents a mature differentiated luminal cell state as it was
predominantly located at the end of the L1 branch, suggesting
that ELF5/KIT may be crucial for differentiation into the secre-
tory L1 cell type, rather than promoting progenitor cell function
as previously described7,8. It appears to be the L1.2 cell state
within the L1 cell type that harbors a luminal-restricted bi-potent
progenitor capacity for differentiation into the more speciﬁed
secretory L1.1 or hormone-responsive L2 cells.
A currently unresolved question of active debate is whether
MaSCs act as bi-potent stem cells that give rise to both lineages of
basal and luminal cells37, or whether homeostasis is mediated
through distinct uni-potent, lineage-restricted basal and luminal
stem cells38. Considering these two models, Monocle could have
yielded a sparsely connected differentiation trajectory separating
basal and luminal lineages, which would have supported a tra-
jectory driven by lineage-restricted basal and luminal uni-potent
progenitor cells on both ends of the spectrum. Instead, the out-
come of our Monocle analysis is in favor of the existence of the
bi-potent stem/progenitor model as it clearly identiﬁed one
continuous trajectory indicative of a common source for both
basal and luminal cell differentiation.
Understanding the origins of breast cancer in its earliest phases
has the potential to advance methods of cancer early detection,
and may ultimately form the basis to prevent cancer progression
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before it turns into a life-threatening disease. Here, we asked
whether the newly identiﬁed cell states correspond to speciﬁc
subtypes of breast cancer, and thus may represent potential
cancer cells-of-origin for the speciﬁc breast cancer subtypes. The
luminal epithelial cell type L2 showed the clearest correlation with
both Luminal A and B subtypes from the Metabric dataset39,
which is in line with previously reported similarities between a
FACS-enriched population of mature luminal cells and the
luminal-like breast cancer subtypes9. The fact that several L2
markers are independently known as breast cancer-associated
antigens such as SYTL2 and ANKRD30A40, and that it shows
highest expression of CDKN1B/p27 as a marker for potential
breast cancer cells of origin31 further corroborates the link
between the hormone-responsive L2 cell type to breast cancer in
general. Interestingly, the cell state closest related to the TNBC
Basal subtype was found to be the luminal progenitor-like
population L1.1. The concept that a luminal cell may be the cell-
of-origin for basal-type breast cancer is not new and has been
previously proposed in the context of BRCA1-driven disease9.
Interestingly, those cell states containing subsets of proliferative
cells, namely B, L1.1 and L2 are predominantly linked to breast
cancer subtypes, which is line with previous reports showing an
association of mammary epithelial cell proliferation in normal
tissues with increased breast cancer risk41.
In summary, our results provide crucial insights into the
spectrum of cellular heterogeneity within the human breast epi-
thelium in unprecedented resolution. Our unbiased analysis of
the single-cell gene signatures from seven human individuals
provide evidence for deﬁned differentiation trajectories to
maintain homeostasis in the adult human breast, as well as dis-
tinct subpopulations of both basal and luminal lineage that may
serve as cells of origin for the different subtypes of breast cancer.
Our single-cell atlas comprising the human breast epithelium will
serve as a resource to map out the deﬁned changes occurring
during breast cancer and therefore form the basis for improved
methods of cancer early detection and possibly strategies for
cancer prevention.
Methods
Origin of tissue samples. Anonymous reduction mammoplasty samples were
acquired from NCI Cooperative Human Tissue Network (CHTN) and from
Department of Surgery, Feinberg School of Medicine, Northwestern University.
Other investigators may have received specimens from the same tissue specimens
obtained through NCI CHTN. Specimens were anonymized then collected and
distributed by CHTN, specimens are covered under collection/distribution of tis-
sues under consent or waiver of consent. Samples were washed in PBS (Corning
21-031-CV) and mechanically dissociated using a razor blade. Dissociated samples
were digested overnight in DMEM (Corning 10-013-CV) with Collagenase Type I,
2 mg/mL (Life Technologies 17100-017). Viable organoids were separated using
differential centrifugation and viably frozen in 50% FBS (Omega Scientiﬁc FB-12),
40% DMEM, and 10% DMSO (Sigma-Aldrich D8418) by volume.
Single-cell RNA sequencing. Viable organoids were thawed and washed using
DMEM, and digested with 0.05% trypsin (Corning 25-052-CI) containing DNase
(Sigma Aldrich D4263-5VL) to generate single cell suspension. Cells were stained
for FACS using ﬂuorescently labeled antibodies for CD31 (eBiosciences 48-0319-
42), CD45 (eBiosciences 48-9459-42), EpCAM (eBiosciences 50-9326-42), CD49f
(eBiosciences 12-0495-82), and SytoxBlue (Life Technologies S34857). We only
proceeded with samples showing at least 80% viability as measured using SytoxBlue
in FACS.
Sorted cells were washed and resuspended at a concentration of ~500 cells/µl.
For microﬂuidics-enabled scRNAseq, cell suspensions were mixed with Fluidigm
C1 Suspension Reagents (Fluidigm 100-5315) at a ratio of 8:2 before loading mix
onto C1 chip (Fluidigm 100-5760). Bright ﬁeld images of captured cells were
collected using a Keyence BZ-X710 microscope (Keyence Corporation, Itasca,
Illinois, USA). Single-cell RNA isolation and ampliﬁcation were performed using
the Fluidigm C1 Single Cell Auto Prep IFC following the Fluidigm Protocol: 100-
7168 I1. RNA spike-in controls were omitted. cDNA library preparation were
performed following the Fluidigm C1 Protocol: 100-7168 I1.
For droplet-enabled scRNAseq, ﬂow cytometry sorted cells were washed in PBS
with 0.04% BSA and reseupended at a concentration of ~1000 cells/µl. Library
generation for 10× Genomics v1 chemistry was performed following the
Chromium Single Cell 3ʹ Reagents Kits User Guide: CG00026 Rev B. Library
generation for 10× Genomics v2 chemistry were performed following the
Chromium Single Cell 3ʹ Reagents Kits v2 User Guide: CG00052 Rev B.
Quantiﬁcation of cDNA libraries was performed using Qubit dsDNA HS Assay
Kit (Life Technologies Q32851) and high-sensitivity DNA chips (Agilent. 5067-
4626). Quantiﬁcation of library construction was performed using KAPA qPCR
(Kapa Biosystems KK4824). For microﬂuidics-enabled scRNAseq libraries, we
generally multiplexed 96 cells per lane on an Illumina HiSeq2500 resulting in a
calculated depth of ~1.6 million reads per cell (Illumina Rapid PE kit v2 402-4002
and Rapid SBS kit v2 FC 401-4022). For droplet-enabled scRNAseq, we used the
Illumina HiSeq4000 platform to achieve an average of 50,000 reads per cell.
Processing of scRNAseq data. After demultiplexing sequencing libraries to
individual cell FASTQ ﬁles (observed average read depth per cell was found to be
~1.6 Million reads), each library was aligned to an indexed GRCh38 RefSeq gen-
ome using RSEM version 1.2.1242, and bowtie2 version 2.2.3 with the following
options enabled: rsem-calculate- expression -p $CORES—bowtie2—paired-end
-output- genome-bam. Fragments Per Kilobase of transcript per Million mapped
reads (FPKM) values were quantiﬁed and concatenated into a resulting gene
expression matrix for each library, which was then loaded into R for subsequent
computational analysis. For quality control ﬁltering, we generally excluded libraries
with less than 900 genes detected. In addition, genes that were not detected in at
least 3 of the cells after this trimming were also removed from further analysis.
Alignment of 3ʹ end counting libraries from droplet-enabled scRNAseq analyses
was completed utilizing 10× Genomics Cell Ranger 1.3.1. Each library was aligned
to an indexed GRCh38 genome using Cell Ranger Count. “Cell Ranger Aggr”
function was used to normalize the number of conﬁdently mapped reads per cells
across the libraries from different individuals utilizing 10× v2 chemistry.
Cluster identiﬁcation using Seurat. For cluster identiﬁcation in both micro-
ﬂuidics- and droplet-enabled scRNAseq datasets, we utilized the Seurat pipeline17.
The data matrices were imported into R and were processed with the Seurat R
package version 1.2.1, where the FPKM values were transformed into log-space
after the aforementioned trimming steps (each gene was expressed in at least three
cells, each cell has at least 900 genes). PCA was performed using highly variable
genes in the trimmed dataset. Using the ﬁrst two PC’s as input, we then performed
density clustering to identify groupings in the data and t-distributed statistical
neighbor embedding (tSNE) to visualize. Using further Seurat functionality, marker
genes for each respective cluster were identiﬁed and used for subsequent analysis.
For droplet-enabled scRNAseq data, we used the Seurat R package version 2.0.0.
Data was read into R as a counts matrix and transformed into log-space. Due to the
difference in gene detection across the two platforms, differences in chemistry for
the library prep, as well as sequencing depth per cell, a minimum cutoff of 500 and
a maximum cut-off of 6000 genes per cell for this dataset was used. In addition,
cells with a percentage of total reads that aligned to the mitochondrial genome
(referred to as percent mito) greater than 10% were removed, since increased
detection of mitochondrial genes can be associated with cells undergoing stress and
cell death43.
To account for the possibility of individual cell complexity driving cluster
separation, we employed Seurat’s “RegressOut” function to reduce the contribution
of both the number of UMI’s and the percent mito. Variable genes were then
determined for subsequent PCA for each separate individual. For tSNE projection
and clustering analysis, we used the ﬁrst ten principal components. We used the
feature plot function to highlight expression of known marker genes for basal (e.g.,
KRT5, KRT14) and luminal cells (e.g., KRT8, KRT18) to identify which clusters
belonged to which epithelial cell type. The speciﬁc markers for each cluster
identiﬁed by Seurat were determined using the “FindAllMarkers” function.
Cluster comparisons and assignment. Cluster speciﬁc marker genes from the
individual library analyses were used as input lists to the previously described gene
scoring method (described in more detail below) to compare cluster signatures in a
pairwise manner between individuals. To visualize pairwise gene scoring results, we
generated heatmaps displaying averaged gene scoring results for each cluster. We
overlaid individual-speciﬁc cluster designations onto these heatmaps to ﬁnd which
individual clusters best match to each other. Clusters were merged together in the
case that multiple clusters scored highly. We performed a separate Seurat analysis
using combined basal cells from all four individuals, and then matched clusters
using the gene scoring method on a set of genes curated to represent a myoe-
pithelial cell fate25 to score and classify the clusters as either Basal (B) or Myoe-
pithelial (Myo) cell state.
Gene scoring. To compare gene signatures and pathways in epithelial sub-
populations, we utilized individual gene scores as described previously12. Brieﬂy,
each score was generated by calculating total gene expression for each of the
analyzed genes and separating them into 25 bins of similar expression. For every
gene in each target pathway or signature, 100 “control” genes were selected from its
corresponding bin and added to a “control” pathway. The resulting “control”
pathway contained an equivalent expression distribution as the target pathway and
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its average represents an equivalent sampling of 100 pathways of equal size to the
target pathway. The expression of genes in the target pathway and the “control”
pathways was averaged across each cell to generate a target score (STarget) and
control score (SCtrl). The cell’s score for the target pathway (SPath) is the difference
between the target score and control score: SPath= STarget− SCtrl. To determine
statistical signiﬁcance, we used the unpaired Wilcox test with a 95% conﬁdence
interval.
Gene set and pathway analysis. Cells belonging to subpopulations were averaged
to serve as a representation of each subgroup, and trimmed to their respective
marker genes as determined by Seurat following log2 transformation. Each sub-
population sample was then uploaded to Ingenuity Pathway Analysis (Ingenuity
Systems, www.ingenuity.com) core analysis feature and compared. A p-value of
0.05 was used as a cut-off to determine signiﬁcant enrichment of a pathway or
annotated gene grouping present in the Ingenuity Knowledge base. In addition,
comprehensive gene set enrichment was done using Enrichr26 based on the cell
type and state speciﬁc marker genes identiﬁed by Seurat.
Immunoﬂuorescence analysis. Tissues were ﬁxed in 4% formaldehyde for 24 h,
dehydrated in solutions of increasing concentrations of ethanol, cleared with
xylene, and embedded in parafﬁn. Slides of 10-μm sections were prepared using a
Leica SM2010 R Sliding Microtome (Leica Biosystems, Wetzlar, Germany). Slides
were heated at 65 °C for 1 h, followed by two 5-min incubations in Histo-Clear
(National Diagnostics, Cat. No. HS-200, Atlanta, Georgia, USA) for parafﬁn
removal. Tissues were rehydrated with solutions of decreasing concentrations of
ethanol, washed in double-distilled H2O and PBS, and subjected to antigen retrieval
using a microwave pressure cooker with 10 mM citric acid buffer (0.05% Tween 20,
pH 6.0). Tissues were blocked in blocking solution (0.1% Tween 20 and 10% Goat
Serum in PBS) for 20 min at room temperature, incubated with primary antibodies
prepared in blocking solution at 4 °C overnight, washed in PBS, incubated with
secondary antibodies diluted in PBS for 1 h at room temperature, and washed in
PBS. Slides were mounted with VECTASHIELD Antifade Mounting Medium with
DAPI (Vector Laboratories, Cat. No. H-1200, Burlingame, California, USA) and
micrographs were taken with the BZ-X700 Keyence ﬂuorescent microscope. For
quantiﬁcation of staining (e.g., ZEB1 and KRT14 staining), we manually counted
positive cells as signal around nuclei (DAPI) and utilized the BZH Hybrid Cell
Count software (Keyence) in at least three different ﬁelds of view using a 40×
objective in at least two different samples.
Primary Antibodies: Estrogen Receptor (ER) rat mAb diluted 1:50 (Cat. No.
916201); KRT14 rabbit pAb diluted 1:500 (Cat. No. PRB-155P) (Biolegend, San
Diego, CA, USA); Androgen Receptor (AR) rabbit mAb diluted 1:400 (Cat. No.
5153); Progesterone Receptor (PR) rabbit mAb diluted 1:1000 (Cat. No. 8757) (Cell
Signaling, Danvers, MA, USA); KRT8 (TROMA-1) mouse mAb diluted 1:500
(DSHB, Iowa City, Iowa, USA); SLPI goat pAb diluted 1:200 (R&D Systems, Cat
No. AF1274-SP, Minneapolis, MN, USA); α-Smooth Muscle Actin mouse mAb
diluted 1:500 (Cat. No GTX60466), Ki67 mAb diluted 1:200 (Cat. No. GTX16667);
TP63 rabbit pAb diluted 1:500 (Cat. No. GTX102425), MUC1 rabbit pAb diluted
1:500 (Cat. No. GTX15481), ACTA2 mouse mAb diluted 1:500 (Cat. No.
GTX60466); TCF4 rabbit pAb diluted 1:500 (Cat. No. GTX54531); E-cadherin
(DCH1) rabbit pAb diluted 1:500 (Cat. No. GTX100443); KRT18 rabbit pAb
diluted 1:500 (Cat. No. GTX112978) (GeneTex, Inc., Irvine, California, USA);
ACTA2 mouse mAb diluted 1:500 (Cat. No. MA511547); NY-BR-1 mouse mAb
diluted 1:500 (Cat. No. MS-1932-P0); KRT14 mouse mAb diluted 1:100 (Cat. No.
MA511599); and KRT18 mouse mAb diluted 1:100 (Cat. No. MA512104) (Thermo
Fisher Scientiﬁc Inc., Carlsbad, California, USA).
Secondary Antibodies: Donkey anti-mouse Cy5.5-conjugated IgG (Novus
Biologicals, Cat. No. NBP1-73774, Littleton, CO, USA); Goat anti-rabbit IgG
conjugated with Alexa Fluor 568 and 488 (Cat. No. A21069 & A11034); Goat anti-
mouse IgG conjugated with Alexa Fluor 568 and 488 (Cat. No. A11004 & A11001);
Goat anti-rat IgG conjugated with Alexa Fluor 488 (Cat. No. A11006); Donkey
anti-rabbit FITC-conjugated IgG (Cat. No. A16030); and Donkey anti-goat IgG
conjugated to FITC and Alexa Fluor 568 (Cat. No. A16006 & A11057) (Thermo
Fisher Scientiﬁc Inc., Carlsbad, California, USA).
Single-cell western blot. Single-cell western blots were completed using the
Single-Cell Western instrument Milo, scWest chips, and reagents from Pro-
teinSimple (San Jose, CA). A standard 6%T scWest chip was re-hydrated in 1×
Suspension Buffer for 15 min at room temperature. A volume of 1 mL of ﬂow
cytometry-sorted human mammary epithelial cells (combined basal and luminal)
at 100,000 cells/mL were settled in medium onto the scWest chip for 15 min at
room temperature. Un-captured cells were washed away with 1 mL of media.
Captured cells were lysed for 10 s, then individual cell protein lysates were elec-
trophoretically separated for 1 min at 240 V, and proteins were UV-captured for 4
min. After running on Milo, the scWest chip was washed 2 × 10min in 1× Wash
Buffer, then probed for mouse anti-cytokeratin 8 (Abcam ab9023) at 200 µg/mL
and rabbit anti-β-tubulin (Abcam ab6046) at 100 µg/mL for 2 h at room tem-
perature. Primary antibodies were diluted in 1 ×Wash Buffer (ﬁnal) containing 5%
(w/v) BSA. After 3 × 10-min washes in 1× Wash Buffer, the scWest chip was
incubated with donkey anti-rabbit IgG Alexa 647 (A-31573 ThermoFisher
Waltham, MA) and donkey anti-mouse IgG Alexa 488 (A-21202 ThermoFisher) at
100 µg/mL in 1× Wash Buffer containing 5% BSA for 1 h in the dark at room
temperature. The chip was then washed 3 × 15 min in 1× Wash Buffer, dried, and
imaged using a Molecular Devices Genepix 4400A (Sunnyvale, CA) (Standard Blue
Filter 500 gain, Standard Red Filter 600 gain). Images were saved as single-color
tiffs and analyzed using Scout software (ProteinSimple).
Reconstructing differentiation trajectories using Monocle. Cell fate decisions
and differentiation trajectories were reconstructed with the Monocle 2 package,
which utilizes reverse graph embedding based on a user deﬁned gene list to gen-
erate a pseudotime plot that can account for both branched and linear differ-
entiation processes. For pseudotemporal analysis of breast epithelial cells in C1
data, we used Monocle version 2.2.0, ordered a combined set of cells from all three
individuals on a list of marker genes as determined by Seurat analysis using up to
20 genes per cluster with least 0.5 power (Supplementary Data 2). Labels of basal
and luminal cells respectively were assigned according to the identity of the cells
from the initial cell sorting and ZEB1 positive cells were labeled based on
expression level >0. For pseudotemporal analysis of droplet-based scRNAseq data,
we ﬁrst ordered the four individuals in Monocle 2.2.0 separately using cell type
markers identiﬁed in the C1 analysis along with the top 20 marker genes for each
subpopulation in Seurat. Next, for each of these four datasets, we identiﬁed genes
differentially expressed between trajectory clusters (States), averaged the gene
expressions values for all cells within each State, and generated a Pearson corre-
lation matrix for these average gene expression value across States. We averaged the
four correlation matrices into one matrix and kept only genes that had an average
Pearson correlation of 0.8 with at least one other gene. Finally, we ordered a
random subsample of 4000 cells (1000 cells from each individual) by the genes
from our correlation analysis that overlapped with Seurat identiﬁed subpopulation
marker genes (Supplementary Data 2).
Comparison of subpopulations to breast cancer subtypes. To learn more about
the relationship of the newly deﬁned normal breast epithelial subpopulations to the
known breast cancer subtypes, we used the gene scoring method to compare each
subpopulation to previously described triple negative breast cancer subtypes. To
this end, we utilized the genes that are speciﬁcally up-regulated in each subtype as
previously reported35,39. To compare each subpopulation to METABRIC derived
molecular subtype signatures, the METABRIC microarray expression dataset was
downloaded and processed using the R Bioconductor package Limma version
3.30.13. Samples were grouped by their annotated molecular subtype, and differ-
entially expressed genes was calculated for each group. The top 20% of the upre-
gulated genes as sorted by log-fold change were then used for downstream scoring.
Code availability. Custom scripts are available at: https://github.com/
kessenbrocklab/Nguyen_Pervolarakis_Nat_Comm_2018.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its supplementary information ﬁles or
from the corresponding author upon reasonable request. All RNAseq data quan-
tiﬁed data matrices along with their associated meta data have been deposited in
the GEO database under accession code GSE113197.
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